Incredible science with top hospital / medical school / researchers vs Unbelievable scam by multi-national thugs
April 2016 -- trial results
Study lead Dr. MacFarlane: "While the turnaround in the abilities and mood of the 32 patients involved has been the most overwhelming factor, the early data has been equally impressive. It shows a huge improvement in the cognitive ability of the patients, with the drug so far proving to be four-times more effective than the current treatment."
January 2015 -- trial start
"A Victorian patient with Alzheimer's disease has become the first in the world to be given a new drug that experts hope will further treatment for the most common form of dementia.
Alfred Health was selected by the overseas drug company to lead a trial to evaluate the novel drug – giving Victorians exclusive access ahead of other research centres.Unlike current medications, Anavex is unique because it is designed to both relieve sufferers’ symptoms and slow the progression of the disease.
Results of the trial could be known within a year and, if positive, will pave the way for a larger clinical trial. Director of Aged Psychiatry at Caulfield Hospital and study lead, Associate Professor Steve Macfarlane said there is need to find better treatments for Alzheimer’s disease.
"Existing drug treatments for Alzheimer’s target a patient’s symptoms, but don’t halt or cure the disease. New trials are focusing on being able to modify the disease’s progression," A/Prof Macfarlane said.
"This trial – Anavex 2-73 – is exciting because data from preclinical studies has indicated potential to both improve memory and slow the disease.
Caulfield Hospital was approached by the US-based developer of the drug because of the reputation of its clinical trials team, and is currently recruiting patients.
To be eligible for the study, patients should have early-stage Alzheimer’s and be on the cognitive enhancer, Aricept."
Remember the Ebola crisis -- the med was approved for treatment without a clinical trial. All AVXL needs is some VIPs have Alzheimer since the safety profile was reportedly very good (if President Reagan is still alive!)
Hopefully Dr. Missing and his gang stop playing around and know how to apply for this -- just filling out few questions and have patients and their families (millions will) lobbying their elected officials.
If the data are good why can the good doc publish -- at least in a 3rd or 4th rate scientific journal. The next big new is 273 increases sex drive and cures ED -- " I can get erection again" -- sex sells, why not!
"In an international study led by Dr Kelly Williams and Associate Professor Ian Blair from the Faculty of Medicine and Health Sciences at Macquarie University, researchers have linked the cause of two seemingly unrelated diseases: motor neurone disease (MND) and frontotemporal dementia" ...
Now can the idiots please call these doc to collaborate more studies using 371
Wow! Did you just start trading today? Complaining to the SEC ?!?! Besides, isn't AVXL being investigated by the SEC?
there are tremendous amounts of abstract / education / researches etc .. about Alzheimer's / dementia / frontotemporal lobe symptoms to be presented. But unfortunately I could NOT find any thing from AVXL. Dr. Missing is totally missing. He had months to prepare / submit. And there would be always late breaking trials / info to be accepted at the last minute ... Why playing around in Greece, Italy ... at those bs meetings. The annual AAN meeting is the biggest in Neurology. And a drug that has been hyped to treat all neuro diseases is MISSING with its CEO. Speechless
I have to confess. I am a medical doctor with a MD degree (not PhD). Due to Obama care downturn, I have to work extra in bashing service to support my family. Please please please reply to my post so that I an earn extra bonus. You may call me name or insult or write anything you want as long as you reply. Thumbing alone will not earn me any credit. Thank you for your participation
Would it it a big bang if they presented some data? But AVXL is SHUT OUT/ missing in action -- NOT a single abstract. The good news for doc Missing and his insiders gang is that they already dumped their shares. Google your DD -- look up dimebon scam -- "the miracle drug that treat all neuro disease". Doc Missing copycated exactly the same scam scheme
The leading drug for AVXL is now a rat poison. Please don't try on Mickey
unless the "leading" 273 is dead. The FDA and world is desperate for "minimal data". If he side effect profile is as good as AVXL said then it does not take much to get approval. Everyone knows -- AVXL does not really need an orphan designation and the sidedishes. ALL they have to do is show positive data on the main course -- AVXL leading drug 273. The PPS will jump 10 times easily. Again there is no need to play aound with 371, 123, 456, 789, ...
Please do your DD -- in 2008 -- now the scam is being repeated
"An old Russian antihistamine drug known as Dimebon has arrested the cognitive and behavioral decline of people with Alzheimer’s as measured on standard tests, according to the results of a medium-sized clinical trial in Russia.A larger clinical trial outside Russia is now under way, and the U.S. Food and Drug Administration (FDA) has indicated its willingness to accept minimal data from that trial to begin the review and approval process for marketing Dimebon ".
Needless to say -- when the Dimebon trial was conducted under true scientific scrunity in the US, it FAILED miserably.
Yes the FDA and the whole world is desparated for an effective treatment. They granted the orphan status but will approve IF AND ONLY IF the drug works -- they will accept "minimal data".
ALL AVXL has to do is to show minimal positive data. And of course they cannot even that their fake trials are conducted outside of the US
be discussed until all the lawsuits are settled or thrown out